Expand IPHA Menu
IPHA MENU

IPHA Latest Press Releases

-- December 22, 2025 --

Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025 Business Wire 1:00 AM

-- December 11, 2025 --

Innate Pharma Releases Its 2026 Financial Calendar Business Wire 1:00 AM

-- November 28, 2025 --

Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025 Business Wire 1:00 AM

-- November 17, 2025 --

Innate Pharma to Present at Jefferies Global Healthcare Conference Business Wire 1:00 AM

-- November 13, 2025 --

Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results Business Wire 1:00 AM

-- November 10, 2025 --

Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL Business Wire 1:00 AM

-- November 5, 2025 --

Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates Business Wire 1:00 AM

-- October 14, 2025 --

Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025 Business Wire 1:00 AM

-- September 17, 2025 --

Innate Pharma Reports First Half 2025 Business Update and Financial Results Business Wire 1:00 AM

-- September 15, 2025 --

Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event Business Wire 1:00 AM

-- September 10, 2025 --

Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update Business Wire 4:30 AM

-- September 2, 2025 --

Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025 Business Wire 1:00 AM

-- August 4, 2025 --

Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025 Business Wire 1:00 AM

-- July 29, 2025 --

Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference Business Wire 1:00 AM
Market Data Delayed 15 Minutes